secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canton Strategic Holdings, Inc. (CNTN)
CIK:        0001861657
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001493152-24-049148
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tharimmune raises $2.02M in private placement for TH104 development
-------------------------------------------------------------------

- Gross proceeds of ~$2.02M from issuance of 961,446 common shares (or equivalents) and warrants for 480,723 shares at $2.10 per unit.
- Warrants exercisable at $2.031/share, starting 6 months after issuance, expiring in 5.5 years.
- Placement led by Gravitas Capital and SDS Capital Group; President Street Global as exclusive agent.
- Net proceeds to fund clinical development of TH104 (pruritus in PBC) and working capital.
- Closing expected on or about December 9, 2024, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861657/000149315224049148/0001493152-24-049148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861657/000149315224049148/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer